• 中國醫(yī)學(xué)科學(xué)院中國協(xié)和醫(yī)科大學(xué)北京協(xié)和醫(yī)院基本外科(北京100032);

目的  探討男性肝細胞癌患者的臨床病理特征、術(shù)后生存及預(yù)后影響因素。
方法  回顧性分析1995年1月至2002年12月期間我科行肝切除術(shù)之155例男性肝細胞癌患者的臨床及隨訪資料,單、多因素分析確定預(yù)后影響因素。
結(jié)果  與同期24例女性患者比較,男性肝細胞癌患者年長5.7歲,并有較高的HBsAg陽性率(80.6% vs 54.2%)和肝硬變比率(87.1% vs 37.5%),P<0.05,其他臨床病理指標差異無統(tǒng)計學(xué)意義(P>0.05)。多因素分析提示,EdmondsonSteiner分級和門靜脈癌栓為男性患者術(shù)后總體生存和無瘤生存的獨立影響因素,衛(wèi)星灶和腫瘤大小僅影響總體生存。
結(jié)論  男性肝細胞癌患者主要的臨床病理特征及術(shù)后生存情況與女性患者相似。腫瘤分化程度和生物學(xué)行為是影響男性肝細胞癌患者術(shù)后生存的主要因素。

引用本文: 周立,芮靜安,王少斌,陳曙光,曲強,遲天毅,魏學(xué),韓凱,張寧,趙海濤. 男性肝細胞癌患者的臨床病理特點及影響因素. 中國普外基礎(chǔ)與臨床雜志, 2007, 14(1): 42-45. doi: 復(fù)制

1.  Lam CM, Yong JL, Chan AO, et al. Better survival in female patients with hepatocellular carcinoma: oral contraceptive pills related? [J]. J Clin Gastroenterol, 2005; 39(6)∶533.
2.  Cong WM, Wu MC, Zhang XH, et al. Primary hepatocellular carcinoma in women of mainland China. A clinicopathologic analysis of 104 patients [J]. Cancer, 1993; 71(10)∶2941.
3.  Lee CC, Chau GY, Lui WY, et al. Better post-resectional survival in female cirrhotic patients with hepatocellular carcinoma [J]. Hepatogastroenterology, 2000; 47(32)∶446.
4.  Tangkijvanich P, Mahachai V, Suwangool P, et al. Gender di-fference in clinicopathologic features and survival of patients with hepatocellular carcinoma [J]. World J Gastroenterol, 2004; 10(11)∶1547.
5.  Tsai TJ, Chau GY, Lui WY, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma [J]. Surgery, 2000; 127(6)∶603.
6.  Yeh CN, Chen MF, Lee WC, et al. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis [J]. J Surg Oncol, 2002; 81(4)∶195.
  1. 1.  Lam CM, Yong JL, Chan AO, et al. Better survival in female patients with hepatocellular carcinoma: oral contraceptive pills related? [J]. J Clin Gastroenterol, 2005; 39(6)∶533.
  2. 2.  Cong WM, Wu MC, Zhang XH, et al. Primary hepatocellular carcinoma in women of mainland China. A clinicopathologic analysis of 104 patients [J]. Cancer, 1993; 71(10)∶2941.
  3. 3.  Lee CC, Chau GY, Lui WY, et al. Better post-resectional survival in female cirrhotic patients with hepatocellular carcinoma [J]. Hepatogastroenterology, 2000; 47(32)∶446.
  4. 4.  Tangkijvanich P, Mahachai V, Suwangool P, et al. Gender di-fference in clinicopathologic features and survival of patients with hepatocellular carcinoma [J]. World J Gastroenterol, 2004; 10(11)∶1547.
  5. 5.  Tsai TJ, Chau GY, Lui WY, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma [J]. Surgery, 2000; 127(6)∶603.
  6. 6.  Yeh CN, Chen MF, Lee WC, et al. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis [J]. J Surg Oncol, 2002; 81(4)∶195.